FMP
Medifast, Inc.
MED
NYSE
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
12.17 USD
0.05 (0.411%)
Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
934.84M
1.53B
1.6B
1.07B
602.46M
697.86M
808.37M
936.38M
1.08B
1.26B
Revenue %
-
63.25
4.75
-32.94
-43.8
15.84
15.84
15.84
15.84
Operating Cash Flow
145.2M
94.55M
194.57M
147.66M
24.48M
72.21M
83.64M
96.89M
112.23M
130M
Operating Cash Flow %
15.53
6.2
12.17
13.77
4.06
10.35
10.35
10.35
10.35
Cap Ex
-5.89M
-34.21M
-16.68M
-6.48M
-7.45M
-8.03M
-9.31M
-10.78M
-12.49M
-14.47M
Cap Ex %
-0.63
-2.24
-1.04
-0.6
-1.24
-1.15
-1.15
-1.15
-1.15
Free Cash Flow
139.31M
60.34M
177.89M
141.17M
17.02M
64.17M
74.33M
86.1M
99.74M
115.53M
Weighted Average Cost Of Capital
Price
12.17
Beta
Diluted Shares Outstanding
10.96M
Costof Debt
3.91
Tax Rate
After Tax Cost Of Debt
2.16
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
16.13M
Total Equity
133.42M
Total Capital
149.54M
Debt Weighting
10.78
Equity Weighting
89.22
Wacc
8.33
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
934.84M
1.53B
1.6B
1.07B
602.46M
697.86M
808.37M
936.38M
1.08B
1.26B
Operating Cash Flow
145.2M
94.55M
194.57M
147.66M
24.48M
72.21M
83.64M
96.89M
112.23M
130M
Cap Ex
-5.89M
-34.21M
-16.68M
-6.48M
-7.45M
-8.03M
-9.31M
-10.78M
-12.49M
-14.47M
Free Cash Flow
139.31M
60.34M
177.89M
141.17M
17.02M
64.17M
74.33M
86.1M
99.74M
115.53M
Wacc
8.33
8.33
8.33
8.33
8.33
Pv Lfcf
59.24M
63.35M
67.74M
72.43M
77.46M
Sum Pv Lfcf
340.21M
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
8.33
Free Cash Flow T1
116.11M
Terminal Value
1.48B
Present Terminal Value
994.73M
Intrinsic Value
Enterprise Value
1.33B
Net Debt
-74.8M
Equity Value
1.41B
Diluted Shares Outstanding
10.96M
Equity Value Per Share
128.59
Projected DCF
128.59 0.905%
